News Image

Boundless Bio to Participate in the Needham Virtual Healthcare Conference

Provided By GlobeNewswire

Last update: Apr 3, 2025

SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary Hornby, President and Chief Executive Officer, will participate in Needham’s Virtual Healthcare Conference.

Read more at globenewswire.com

BOUNDLESS BIO INC

NASDAQ:BOLD (7/30/2025, 4:30:02 PM)

After market: 1.19 0 (0%)

1.19

0 (0%)



Find more stocks in the Stock Screener

Follow ChartMill for more